Category: Diseases & Conditions
Global Diseases & Conditions
-
Tuberculosis Testing Market by Test (Culture Based Tests, Drug Susceptibility Testing, Nucleic Acid Testing), End User (Hospital, Laboratories) - Global Forecast 2024-2030
... and expected to reach USD 2.76 billion in 2024, at a CAGR 7.38% to reach USD 4.23 billion by 2030. Global Tuberculosis Testing Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Tuberculosis Diagnostics Market by Test Type (Drug-susceptibility Testing, Laboratory Methods, Mantoux Test), Type (Point-of-Care Technologies, Rapid Test), End_User - Global Forecast 2024-2030
... and expected to reach USD 3.17 billion in 2024, at a CAGR 5.48% to reach USD 4.38 billion by 2030. Global Tuberculosis Diagnostics Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Women’s Health Diagnostics Market by Type (Point-of-Care, Self Check), Application (Breast Cancer Testing, Cervical Cancer Testing, Infectious Disease Testing), End-User - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 46.82 billion in 2024, at a CAGR 9.25% to reach USD 80.59 billion by 2030. Global Women’s Health Diagnostics Market FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Respiratory Care Devices Market by Product (Consumables & Accessories, Diagnostic Devices, Monitoring Devices), Indication (Asthma, Chronic Obstructive Pulmonary Disease, Infectious Disease), End-User - Global Forecast 2024-2030
... USD 19.87 billion in 2023 and expected to reach USD 21.08 billion in 2024, at a CAGR 6.39% to reach USD 30.66 billion by 2030. Global Respiratory Care Devices Market The respiratory care devices market ... Read More
-
COVID-19 Vaccines Market by Product Type (Monovalent Vaccine, Multivalent Vaccine), End-User (Academic & Research Centers, Clinics, Hospitals), Patient Type - Global Forecast 2024-2030
... 2023 and expected to reach USD 237.12 billion in 2024, at a CAGR 10.55% to reach USD 434.83 billion by 2030. Global COVID-19 Vaccines Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Cancer Immunotherapy Drugs Market by Type (Cancer Vaccines, Checkpoint Inhibitors, Immunomodulators), Indication (Breast Cancer, Colorectal Cancer, Head & Neck Cancer), End-user - Global Forecast 2024-2030
... 215.29 billion in 2023 and expected to reach USD 243.31 billion in 2024, at a CAGR 13.10% to reach USD 509.93 billion by 2030. Global Cancer Immunotherapy Drugs Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Conjugate Vaccine Market by Type (Monovalent, Multivalent), Indication (Diphtheria & Pertussis, Influenza, Meningococcal), Pathogen Type, End-User - Global Forecast 2024-2030
... to reach USD 43.92 billion in 2024, at a CAGR 10.81% to reach USD 81.42 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Conjugate Vaccine Market. It offers ... Read More
-
Anemia Drugs Market by Drug (Alglucerase Injection, Carbonyl Iron, Cyanocobalamin), Type (Aplastic Anemia, Chronic Kidney Disease Anemia, Hemolytic Anemia), Route of Administration, End-Users - Global Forecast 2024-2030
... USD 19.55 billion in 2023 and expected to reach USD 21.24 billion in 2024, at a CAGR 10.76% to reach USD 39.99 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Allergy Vaccine Market by Allergy Type (Allergic Asthma, Cat Dander Allergy, Grass Pollen Hypersensitivity), Vaccine Type (Cat Allergy Vaccine, House Dust Mite Allergy Vaccine, Injectable MPL Allergy Vaccine), Application, End User - Global Forecast 2024-
... The Allergy Vaccine Market size was estimated at USD 1.28 billion in 2023 and expected to reach USD 1.43 billion in 2024, at a CAGR 11.51% to reach USD 2.75 billion by 2030. FPNV Positioning ... Read More
-
Digital Therapeutic Devices Market by Product (Insulin Pumps, Pain Management Devices, Rehabilitation Devices), Application (Preventive, Treatment) - Global Forecast 2024-2030
... expected to reach USD 7.41 billion in 2024, at a CAGR 18.39% to reach USD 20.42 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Digital Therapeutic Devices Market. ... Read More
-
Intravenous Infusion Pump Market by Product (Ambulatory Infusion Pumps, Enteral Infusion Pumps, Implantable Infusion Pumps), Disease Indication (Analgesia or Pain Management, Chemotherapy, Diabetes) - Global Forecast 2024-2030
... at USD 4.44 billion in 2023 and expected to reach USD 4.85 billion in 2024, at a CAGR 9.85% to reach USD 8.57 billion by 2030. Global Intravenous Infusion Pump Market FPNV Positioning Matrix The ... Read More
-
Stereotactic Surgery Devices Market by Device (Gamma Knife, Line Accelerator (LINAC) Machines, Proton Beam), Application (Arteriovenous Malformations Treatment, Brain Tumor Treatment, Epilepsy Treatment), End-User - Global Forecast 2024-2030
... estimated at USD 25.23 billion in 2023 and expected to reach USD 26.47 billion in 2024, at a CAGR 5.29% to reach USD 36.21 billion by 2030. Global Stereotactic Surgery Devices Market FPNV Positioning Matrix ... Read More
-
Bladder Cancer Therapeutics Market by Treatment Type (Chemotherapy, Gene Therapy, Immunotherapy), Bladder Cancer Type (Invasive Bladder Cancer, Squamous Cell Bladder Cancer, Superficial Bladder Cancer), End-User - Global Forecast 2024-2030
... was estimated at USD 5.21 billion in 2023 and expected to reach USD 5.56 billion in 2024, at a CAGR 7.23% to reach USD 8.49 billion by 2030. Global Bladder Cancer Therapeutics Market FPNV Positioning ... Read More
-
Alzheimer's Disease Drugs Market by Drug Class (Cholinergic, Combined Drug, Memantine), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) - Global Forecast 2024-2030
... in 2023 and expected to reach USD 4.74 billion in 2024, at a CAGR 10.10% to reach USD 8.45 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Alzheimer's ... Read More
-
Neuroprotection Market by Product (Apoptosis Inhibitors, Free Anti-Inflammatory Agents, Glutamate Antagonists), Treatment (Alzheimer's Disease, Amyotrophic Lateral Sclerosis, Brain Injury), Application - Global Forecast 2024-2030
... 2023 and expected to reach USD 16.20 billion in 2024, at a CAGR 9.86% to reach USD 28.52 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Neuroprotection Market. ... Read More
-
HIV or AIDS Diagnostics Market by Product Type (Instruments, Kits & Reagents), Test Type (ELISA, Nucleic Acid Tests, Rapid Tests), End User - Global Forecast 2024-2030
... at USD 6.84 billion in 2023 and expected to reach USD 7.46 billion in 2024, at a CAGR 9.12% to reach USD 12.62 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Auto-disable Syringes Market by Indication (Infectious Diseases, Inflammatory/Auto-Immune Diseases), Application (Blood Collection, Drug Delivery, Vaccination), End-User - Global Forecast 2024-2030
... to reach USD 25.94 billion in 2024, at a CAGR 11.54% to reach USD 50.01 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Auto-disable Syringes Market. It offers ... Read More
-
Influenza Vaccine Market by Vaccine Type (Inactivated, Live Attenuated, Recombinant), Age Group (Adolescent Vaccination, Adult Vaccination, Infant Vaccination), Administration Route, Distribution Channel - Global Forecast 2024-2030
... 7.92 billion in 2023 and expected to reach USD 8.61 billion in 2024, at a CAGR 9.01% to reach USD 14.49 billion by 2030. Global Influenza Vaccine Market FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
HIV Clinical Trials Market by Phase (Phase I, Phase II, Phase III), Study Design (Expanded Access Studies, Interventional Studies, Observational Studies), Sponsor - Global Forecast 2024-2030
... USD 1.05 billion in 2023 and expected to reach USD 1.13 billion in 2024, at a CAGR 7.83% to reach USD 1.79 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Therapeutic Vaccines Market by Vaccines Type (Auto-Immune Diseases Vaccines, Chronic Disease Vaccines, Infectious Diseases Vaccines), Disease Indication (Dengue, DTP, Hepatitis), Administration, End-User - Global Forecast 2024-2030
... 30.08 billion in 2023 and expected to reach USD 33.05 billion in 2024, at a CAGR 10.35% to reach USD 59.95 billion by 2030. Global Therapeutic Vaccines Market FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Next-Generation Gynecological Cancer Diagnostics Market by Components (Consumables, Instruments, Software), Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR)), Indication, End User - Global Forecast 2024-2030
... USD 2.13 billion in 2023 and expected to reach USD 2.32 billion in 2024, at a CAGR 10.49% to reach USD 4.29 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Endoluminal Suturing Devices Market by Application (Bariatric Surgery, Gastroesophageal Reflux Disease Surgery, Gastrointestinal Surgery), End-User (Ambulatory Surgical Centers, Hospitals) - Global Forecast 2024-2030
... in 2023 and expected to reach USD 48.44 billion in 2024, at a CAGR 12.86% to reach USD 100.19 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Endoluminal ... Read More
-
Non-opioid Pain Patches Market by Patch Type (Capsaicin Patches, Diclofenac Patches, Ketoprofen Patches), Indication (Arthritis, Back Pain, Fibromyalgia), Distribution - Global Forecast 2024-2030
... in 2023 and expected to reach USD 790.97 million in 2024, at a CAGR 12.88% to reach USD 1,637.77 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Non-opioid ... Read More
-
Umbilical Cord Blood Banking Market by Storage (Private Cord Blood Banks, Public Cord Blood Banks), Application (Bone Marrow Failure Syndrome, Immune Deficiencies, Leukemia) - Global Forecast 2024-2030
... estimated at USD 28.34 billion in 2023 and expected to reach USD 33.08 billion in 2024, at a CAGR 16.80% to reach USD 84.08 billion by 2030. Global Umbilical Cord Blood Banking Market FPNV Positioning ... Read More
-
Osteoarthritis Pain Drug Market by Drug Class (Corticosteriods, NSAIDs, Viscosupplementation), Route of Administration (Oral, Parenteral, Topical), Distribution Channel - Global Forecast 2024-2030
... 2023 and expected to reach USD 8.54 billion in 2024, at a CAGR 6.47% to reach USD 12.47 billion by 2030. Global Osteoarthritis Pain Drug Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
Research Assistance
